Corcept Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $583.4M
Liabilities Breakdown FY2022
Total Liabilities: $81.6M
Asset Breakdown
Total Assets: $583.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $66.3M | 11.4% |
| Accounts Receivable | $31.1M | 5.3% |
| Inventory | $6.1M | 1.0% |
| Property, Plant & Equipment | $633.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $479.3M | 82.2% |
Liabilities Breakdown
Total Liabilities: $81.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.0M | 14.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $69.6M | 85.3% |